Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202

Department of Tumor Biology, The University of Texas MD Anderson Cancer Center, Houston 77030, USA.
Oncogene (Impact Factor: 8.46). 02/1999; 18(3):807-11. DOI: 10.1038/sj.onc.1202369
Source: PubMed


Interferons (IFNs) can exert cytostatic and immunomodulatory effects on carcinoma cells. In particular, growth inhibition of human prostate carcinoma by IFNs has been demonstrated both in vitro and in vivo. p202 is a 52 kd nuclear phosphoprotein known to be induced by IFNs. In this report, we showed that the expression of p202 was associated with an anti-proliferative effect on human prostate cancer cells. More importantly, cells that expressed p202 showed reduced ability to grow in soft-agar, indicating a loss of transformation phenotype. Our data suggest that p202 is a growth inhibitor gene in prostate cancer cells and its expression may also suppress transformation phenotype of prostate cancer cells.

Download full-text


Available from: Divaker Choubey, Nov 03, 2014
  • Source
    • "This domain is associated with apoptosis and interferon response, and has been suggested to be important for p200 protein dimerization. The functions of the p200 family members appear to be distinct from one another in that certain family members, IFI-16, p202, p204, have been clearly shown to have anti-proliferative effects, while others have not: p203, MNDA [6] [7] [8]. In addition, AIM2, was described as a potential tumor suppressor gene in melanoma, is able to inhibit murine fibroblast growth, and enhance susceptibility to apoptosis under reduced serum conditions [9]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: p205 is a member of the interferon-inducible p200 family of proteins that regulate cell proliferation. Over-expression of p205 inhibits cell growth, although its mechanism of action is currently unknown. Therefore, we evaluated the effect of p205 on the p53 and Rb-dependent pathways of cell cycle regulation. p205 expression results in elevated levels of p21, and activates the p21 promoter in vitro in a p53-dependent manner. In addition, p205 induces increased expression of Rb, and binds directly to Rb and p53. Interestingly, p205 also induces growth inhibition independent of p53 and Rb by delaying G2/M progression in proliferating cells, and is a substrate for Cdk2 kinase activity. Finally, we have identified other binding partners of p205 by a yeast two-hybrid screen, including the paired homeodomain protein HoxB2. Taken together, our results indicate that p205 induces growth arrest by interaction with multiple transcription factors that regulate the cell cycle, including but not entirely dependent on the Rb- and p53-mediated pathways of growth inhibition.
    Full-text · Article · Mar 2006 · FEBS Letters
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The overexpression of HER-2/neu proto-oncogene has been found in a variety of human cancers. In particular, the amplification and overexpression of HER-2/neu gene were found in 20-30% of breast and ovarian cancer patients with a decreased survival and an increased relapse rates. To target the breast cancer cells overexpressing HER-2/neu mRNA, a novel approach is described that combines the antisense principle and the biochemical property of a translation regulator, an iron responsive element (IRE). This report shows that a HER-2/neu antisense IRE-reporter gene can be preferentially expressed in the breast cancer cells that overexpress HER-2/neu mRNA. This antisense IRE-mediated gene expression system may be applied broadly to target other cell type that uniquely expresses or overexpresses a known gene.
    Preview · Article · Jun 1998 · Biochemical and Biophysical Research Communications
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Interferons have been shown to exert antiviral, cell growth regulatory, and immunomodulatory effects on target cells (16, 37). Both type I (a and b) and type II (g) interferons regulate cellular activities by specifically inducing the expression or activation of endogenous proteins that perform distinct biolog- ical functions. The HIN-200 (hematopoietic interferon-induc- ible nuclear proteins with a 200-amino-acid repeat) gene fam- ily found on human and mouse chromosome 1 is positively regulated by type I and II interferons (15, 27, 30). The HIN- 200 family of proteins consists of a number of highly homolo- gous human and murine proteins with similar primary amino acid sequences and biological characteristics. The human HIN- 200 family members include IFI 16 (39), the myeloid nuclear differentiation antigen (MNDA) (2, 18), and AIM-2 (absent in melanoma) (17), while the mouse HIN-200 family members include p202 (3), p203 (20), p204 (3), and D3 (38). There are a number of reviews that elegantly outline the biochemical characteristics of these proteins and their patterns of expres- sion (15, 27, 30). Recently, there have been a number of re- ports examining possible cellular functions of HIN-200 pro- teins. It is now clear that these proteins play a role in modulating cell growth and perhaps in vivo differentiation, and the newest member of the HIN-200 family, AIM-2, has been identified as a possible tumor suppressor protein. Some family members are transcriptional regulators, acting either directly by binding DNA at a promoter or indirectly by modulating the function of other cellular transcription factors. Clearly, there is much still to learn about the biological functions of these proteins and how significant a role they play during an inter- feron response. While it is clear that the human and mouse family members share many biochemical and structural char- acteristics, it is unclear which, if any, of the currently identified murine HIN-200 proteins are functional homologs of the dif- ferent human HIN-200 family members. This review will briefly cover the structural and biochemical properties of HIN- 200 proteins but will concentrate on the molecular and biolog- ical functions of these molecules.
    Preview · Article · Oct 1999 · Molecular and Cellular Biology
Show more